Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights| Protein Name | Dopamine receptor D3 |
| Gene Name | DRD3 |
| Uniprot | P35462 (Human); P30728 (Mouse) |
| Synonym | D3DR; ETM1; FET1; D(3) dopamine receptor; essential tremor 1 |
| Background | DRD3 is a member of the dopamine receptor family, which is classified into two groups: the D1-like receptor class containing DRD1 and DRD5 and the D2-like receptor class containing DRD3, DRD3, and DRD4. DRD3 has the highest affinity for dopamine. DRD3 is a G-protein coupled receptor that inhibits adenylyl cyclase activity. Its signaling pathway is primarily mediated by interaction with and activation of heterotrimeric GTP-binding proteins (G proteins). GPCRs control pro-survival signaling pathways (e.g. ERK and Akt) that are broadly important in human cancer. |
Creative Biolabs offers comprehensive range of membrane protein products empowers your unique research needs.
| CAT# | Product Name | Expression System | Protein Length | Solubilizing Agents |
| S01YF-1023-KX282 | NativeExtract™ Human DRD3 Membrane Protein (Full length, Super Nanodisc) | HEK293 cells | Full length | Native Nanodisc |
| MPX3534K | MemDX™ Membrane Protein Human DRD3 Expressed in vitro E.coli expression system, Full Length | E.coli cell-free | Full length | Detergent |
| Please for more products or customization | ||||
L**a: I was very impressed with Creative Biolabs' ability to handle complex projects.
27/Sep/2023
K***n: Creative Biolabs has a deep understanding of the field, and their customer service is second to none.
03/Jun/2024
We provide tailored solutions to meet your specific requirements. Please for more services.
Pharmacogenetic Studies
Creative Biolabs offers pharmacogenetic studies services. Pharmacogenetic investigations rigorously explore the intricate nexus between intrinsic genetic variations within the DRD3 gene and an individual's differential responses to diverse pharmacological interventions. These compelling empirical observations underscore the profound utility of such genotype-phenotype correlations. They perhaps offer crucial insights for the future development of highly targeted therapies, potentially enhancing their efficacy and precision for distinct patient cohorts.
Functional Studies
Creative Biolabs offers functional studies services. Mechanistic investigations into the DRD3 frequently entail the utilization of in vitro cellular models. These controlled experimental systems serve to elucidate the nuanced impact of specific DRD3 gene variations on intrinsic cellular phenotypes and behavior. For instance, transcriptomic profiling via RNA sequencing (RNA-seq) may be strategically employed in this context. Such advanced molecular techniques permit the comprehensive characterization of global gene expression alterations, often observed subsequent to pharmacological perturbation with either DRD3 antagonists or agonists. They provide a deeper understanding of the underlying biomolecular mechanisms governing DRD3 function, which, in turn, can significantly guide the rational design and development of novel therapeutic strategies.
Creative Biolabs offers comprehensive and innovative services to drive the development of DRD3 cell therapy. Please for more services.
Stable Cell Line Generation
Creative Biolabs offers stable cell line development services. The meticulous establishment of stable cellular lineages constitutively expressing the DRD3 is a critical endeavor. Such cell lines are frequently engineered through the employment of extrachromosomal DNA constructs, specifically plasmid vectors, alongside the indispensable application of selectable genetic elements. For instance, a common methodology involves the transduction of HEK293 cells with recombinant vectors that encode DRD3, occasionally engineered for chimeric expression with Green Fluorescent Protein (GFP). They can be precisely employed for protracted investigations into fundamental DRD3 function, perhaps accelerating the discovery of novel therapeutic agents.
Ex VivoManipulation and Cell Transfer
Creative Biolabs offers Ex Vivomanipulation and cell transfer services. The ex vivo pharmacological modulation of specific cellular populations, followed by their subsequent reinfusion, represents an emergent and perhaps compelling therapeutic modality within the rapidly evolving landscape of DRD3 cell therapy. This innovative methodology possesses considerable translational potential. It may be judiciously extrapolated to address a broader spectrum of cellular types and diverse pathophysiological conditions, thereby offering a strategic therapeutic avenue for disorders characterized by aberrant DRD3 signaling. The precise mechanisms underpinning this observed therapeutic effect warrant further intricate elucidation, yet the preliminary findings are certainly encouraging for future clinical development.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
